06 October 2020>: Articles
Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review
Unusual clinical course
Yanhua Yue * , Wei Wei * , Yanting Guo B , Fei Wang C , Weimin Dong D , Yue Liu B , Yan Lin G , Yang Cao G , Weiying Gu A*DOI: 10.12659/AJCR.925151
Am J Case Rep 2020; 21:e925151
Figure 2. Molecular findings before the first round of induction chemotherapy with modified IA. (A) Next-generation sequencing showing a JAK2 gene mutation in exon 18 (c. 2385 G >T: p.R795S). (B) Sanger sequencing showing the absence of the JAK2 R795S gene mutation in hair and nails of the same patient.